financetom
Business
financetom
/
Business
/
IOC Q4FY21: Seeing 15% impact on demand due to 2nd wave of COVID, says management
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
IOC Q4FY21: Seeing 15% impact on demand due to 2nd wave of COVID, says management
May 20, 2021 2:37 AM

Indian Oil Corporation (IOC), India's biggest oil firm, on Wednesday reported a net profit of Rs 8,781.30 crore for the January-March quarter, helped by higher refining margins.

Detailing the numbers, Shrikant Madhav Vaidya, Chairman of the company said that there has been a 15 percent impact on demand due to the second wave of COVID. However, he clarified that the impact is not as much as it was last year.

“Last year there was a nationwide lockdown due to which the refinery runs had come to nearly 47-49 percent in the month of April. This year because different geographies have different type of lockdown the refinery runs in April were at about 96 percent and in the month of May it is 84 percent. So 15 percent is the demand destruction that we are seeing at this point of time,” he said in an interview to CNBC-TV18.

Vaidya said that gasoline and diesel cracks are between USD 4-5/barrel, adding that the Singapore GRM currently is at about USD 1.79/barrel.

He also said that the company was able to ramp up capacities in the petchem segment beyond 100 percent and the spreads too are doing well. “Combined with the spreads and the 100 percent capacity utilization, we have been able to register good petchem margins,” he said.

The company’s current debt stands at Rs 1.02 lakh crore. However, he said that the debt will remain at the same level despite planned capex of around Rs 26,000 crore.

Vaidya also said that the company is making investments in hydrogen and electric vehicles.

Watch the video for more.

(Edited by : Pranati Deva)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Meta pushes back on US FTC's bid to amend 2020 privacy settlement
Meta pushes back on US FTC's bid to amend 2020 privacy settlement
Apr 4, 2024
By Granth Vanaik (Reuters) - Meta Platforms ( META ) has rebuffed an attempt by the U.S. Federal Trade Commission to amend a 2020 privacy settlement, noting that it had voluntarily disclosed two technical errors related to its Messenger Kids app to the agency. Meta disclosed the bugs in July 2019, the Facebook-parent said in a filing on Thursday, adding...
Boehringer to lay off salespeople as Humira biosimilar sales lag
Boehringer to lay off salespeople as Humira biosimilar sales lag
Apr 4, 2024
April 4 (Reuters) - Boehringer Ingelheim on Thursday said it will lay off some of its salesforce due to poor U.S. sales of its biosimilar version of AbbVie's ( ABBV ) blockbuster arthritis treatment Humira. The German drugmaker said it planned to reduce its customer-facing teams in favor of a hybrid in-person and virtual sales model by June 30, in...
Soccer-Chelsea's Pochettino hopes dramatic Man United win is turning point
Soccer-Chelsea's Pochettino hopes dramatic Man United win is turning point
Apr 4, 2024
LONDON, April 4 (Reuters) - Chelsea coach Mauricio Pochettino said he hoped that the high drama of Thursday's 4-3 comeback win over Manchester United ( MANU ) will prove a turning point in the Blues' inconsistent season and the sometimes strained relationship between him and the fans. Pochettino raced onto the pitch at the final whistle after hat-trick hero Cole...
J&J recommends shareholders to reject 'mini-tender' offer by TRC Capital Investment
J&J recommends shareholders to reject 'mini-tender' offer by TRC Capital Investment
Apr 4, 2024
(Reuters) - Johnson & Johnson ( JNJ ) said on Thursday it has recommended its shareholders to reject an unsolicited mini-tender offer by TRC Capital Investment Corporation for about 0.04% of its common stock. The drugmaker said Ontario-based TRC Capital has offered to purchase up to 1 million shares of J&J's stock at a price of $151.23 per share in...
Copyright 2023-2026 - www.financetom.com All Rights Reserved